Connection

PABLO C OKHUYSEN to Middle Aged

This is a "connection" page, showing publications PABLO C OKHUYSEN has written about Middle Aged.
Connection Strength

0.220
  1. Clinical features and molecular epidemiology of diarrheagenic Escherichia coli pathotypes identified by fecal gastrointestinal multiplex nucleic acid amplification in patients with cancer and diarrhea. Diagn Microbiol Infect Dis. 2017 Nov; 89(3):235-240.
    View in: PubMed
    Score: 0.023
  2. Viral associated diarrhea in immunocompromised and cancer patients at a large comprehensive cancer center: a 10-year retrospective study. Infect Dis (Lond). 2017 Feb; 49(2):113-119.
    View in: PubMed
    Score: 0.022
  3. A single-nucleotide polymorphism in the gene encoding osteoprotegerin, an anti-inflammatory protein produced in response to infection with diarrheagenic Escherichia coli, is associated with an increased risk of nonsecretory bacterial diarrhea in North American travelers to Mexico. J Infect Dis. 2009 Feb 15; 199(4):477-85.
    View in: PubMed
    Score: 0.013
  4. Influence of host interleukin-10 polymorphisms on development of traveler's diarrhea due to heat-labile enterotoxin-producing Escherichia coli in travelers from the United States who are visiting Mexico. Clin Vaccine Immunol. 2008 Aug; 15(8):1194-8.
    View in: PubMed
    Score: 0.012
  5. PCR-based assay using occult blood detection cards for detection of diarrheagenic Escherichia coli in specimens from U.S. travelers to Mexico with acute diarrhea. J Clin Microbiol. 2008 Jul; 46(7):2227-30.
    View in: PubMed
    Score: 0.012
  6. Enterotoxigenic Escherichia coli heat-labile toxin seroconversion in US travelers to Mexico. J Travel Med. 2008 May-Jun; 15(3):156-61.
    View in: PubMed
    Score: 0.012
  7. A novel single-nucleotide polymorphism in the lactoferrin gene is associated with susceptibility to diarrhea in North American travelers to Mexico. Clin Infect Dis. 2007 Apr 01; 44(7):945-52.
    View in: PubMed
    Score: 0.011
  8. A retrospective, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin, or ceftriaxone. Pharmacotherapy. 2005 Oct; 25(10):1303-9.
    View in: PubMed
    Score: 0.010
  9. Outcomes of Immune Checkpoint Inhibitor-related Diarrhea or Colitis in Cancer Patients With Superimposed Gastrointestinal Infections. Am J Clin Oncol. 2021 08 01; 44(8):402-408.
    View in: PubMed
    Score: 0.008
  10. Neutropenic Enterocolitis: Clinical Features and Outcomes. Dis Colon Rectum. 2020 03; 63(3):381-388.
    View in: PubMed
    Score: 0.007
  11. Microbial Diversity and Composition Is Associated with Patient-Reported Toxicity during Chemoradiation Therapy for Cervical Cancer. Int J Radiat Oncol Biol Phys. 2020 05 01; 107(1):163-171.
    View in: PubMed
    Score: 0.007
  12. The BE GONE trial study protocol: a randomized crossover dietary intervention of dry beans targeting the gut microbiome of overweight and obese patients with a history of colorectal polyps or cancer. BMC Cancer. 2019 Dec 18; 19(1):1233.
    View in: PubMed
    Score: 0.007
  13. Gastrointestinal Adverse Events Observed After Chimeric Antigen Receptor T-Cell Therapy. Am J Clin Oncol. 2019 10; 42(10):789-796.
    View in: PubMed
    Score: 0.007
  14. Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis. J Immunother Cancer. 2019 09 05; 7(1):242.
    View in: PubMed
    Score: 0.007
  15. Recurrent Clostridium difficile infection is associated with treatment failure and prolonged illness in cancer patients. Eur J Gastroenterol Hepatol. 2019 01; 31(1):128-134.
    View in: PubMed
    Score: 0.006
  16. Fecal Indole as a Biomarker of Susceptibility to Cryptosporidium Infection. Infect Immun. 2016 08; 84(8):2299-306.
    View in: PubMed
    Score: 0.005
  17. Does chemotherapy cause viral relapse in cancer patients with hepatitis C infection successfully treated with antivirals? Clin Gastroenterol Hepatol. 2014 Jun; 12(6):1051-4.e1.
    View in: PubMed
    Score: 0.004
  18. Patterns of illness in travelers visiting Mexico and Central America: the GeoSentinel experience. Clin Infect Dis. 2011 Sep; 53(6):523-31.
    View in: PubMed
    Score: 0.004
  19. Resumption of HIV replication is associated with monocyte/macrophage derived cytokine and chemokine changes: results from a large international clinical trial. AIDS. 2011 Jun 01; 25(9):1207-17.
    View in: PubMed
    Score: 0.004
  20. Seasonality of diarrheagenic Escherichia coli pathotypes in the US students acquiring diarrhea in Mexico. J Travel Med. 2011 Mar-Apr; 18(2):121-5.
    View in: PubMed
    Score: 0.004
  21. Campylobacter jejuni is not an important pathogen as a cause of diarrhea in US travelers to Mexico. J Travel Med. 2011 Jan-Feb; 18(1):56-8.
    View in: PubMed
    Score: 0.004
  22. Characterization of norovirus-associated traveler's diarrhea. Clin Infect Dis. 2010 Jul 15; 51(2):123-30.
    View in: PubMed
    Score: 0.004
  23. Prevention of travelers' diarrhea with rifaximin in US travelers to Mexico. J Travel Med. 2010 Mar-Apr; 17(2):111-7.
    View in: PubMed
    Score: 0.003
  24. Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial. Lancet. 2008 Jun 14; 371(9629):2019-25.
    View in: PubMed
    Score: 0.003
  25. Loperamide plus azithromycin more effectively treats travelers' diarrhea in Mexico than azithromycin alone. J Travel Med. 2007 Sep-Oct; 14(5):312-9.
    View in: PubMed
    Score: 0.003
  26. Association of interleukin-8 polymorphism and immunoglobulin G anti-toxin A in patients with Clostridium difficile-associated diarrhea. Clin Gastroenterol Hepatol. 2007 Aug; 5(8):964-8.
    View in: PubMed
    Score: 0.003
  27. Fecal cytokines and markers of intestinal inflammation in international travelers with diarrhea due to Noroviruses. J Med Virol. 2006 Jun; 78(6):825-8.
    View in: PubMed
    Score: 0.003
  28. A common polymorphism in the interleukin 8 gene promoter is associated with Clostridium difficile diarrhea. Am J Gastroenterol. 2006 May; 101(5):1112-6.
    View in: PubMed
    Score: 0.003
  29. Noroviruses as a cause of traveler's diarrhea among students from the United States visiting Mexico. J Clin Microbiol. 2005 Dec; 43(12):6126-9.
    View in: PubMed
    Score: 0.003
  30. Evaluation of recombinant oocyst protein CP41 for detection of cryptosporidium-specific antibodies. Clin Diagn Lab Immunol. 2005 Feb; 12(2):268-72.
    View in: PubMed
    Score: 0.002
  31. Substance P expression correlates with severity of diarrhea in cryptosporidiosis. J Infect Dis. 2003 Jul 15; 188(2):290-6.
    View in: PubMed
    Score: 0.002
  32. Expression of IL-15 and IL-4 in IFN-gamma-independent control of experimental human Cryptosporidium parvum infection. Cytokine. 2001 Jul 07; 15(1):39-46.
    View in: PubMed
    Score: 0.002
  33. The infectivity of Cryptosporidium parvum in healthy volunteers. N Engl J Med. 1995 Mar 30; 332(13):855-9.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.